Biodesix, Inc. (NASDAQ:BDSX) Q4 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Biodesix, Inc. Fourth Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Biodesix Inc (BDSX)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | AIGH Investment Partners Orin Hirschman | 758,328 | $10,995,756 | 1.5% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.80 | 20,000 | $236,064.00 | 1,563,210 | 2026-01-26 | Filing | |
| $11.81 | 80,000 | $944,672.00 | 1,543,210 | 2026-01-23 | Filing | |
| $10.96 | 82,465 | $903,560.76 | 1,463,210 | 2026-01-22 | Filing | |
| $7.04 | 142,045 | $999,996.80 | 1,380,745 | 2025-09-19 | Filing | |
| $6.17 | 3,056 | $18,853.99 | 1,238,700 | 2025-09-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.78 | 556 | $7,103.23 | 10,359 | 2026-02-23 | Filing | |
| $12.78 | 535 | $6,834.95 | 9,819 | 2026-02-23 | Filing | |
| $12.78 | 535 | $6,834.95 | 16,231 | 2026-02-23 | Filing | |
| $12.78 | 211 | $2,695.65 | 1,586 | 2026-02-23 | Filing | |
| $12.78 | 1,490 | $19,035.64 | 48,767 | 2026-02-23 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 458,438 | $6,647,351 | 0.01% | |
| 2. | 44,783 | $649,353 | 0.61% | |
| 3. | 11,750 | $170,375 | 0.11% | |
| 4. | 171 | $2,480 | 0% | |
| 5. | 13 | $189 | 0% |
News See All
Biodesix, Inc. (NASDAQ:BDSX) Q3 2025 Earnings Call Transcript
Christopher Brinzey: Thank you, operator, and good afternoon, everyone. Today, Biodesix released results from the third quarter of 2025.
Biodesix, Inc. (NASDAQ:BDSX) Q2 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Biodesix Q2 2025 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.
Biodesix, APAPP Partner to Launch First CME-Accredited Education Program for Lung Cancer Biomarkers
Biodesix Inc. (NASDAQ:BDSX) is one of the best penny stocks under $1 to buy now. On June 10, Biodesix announced a new partnership with the Association of Pulmonary Advanced Practice Providers/APAPP.
12 Best Penny Stocks Under $1 to Buy Now
On July 18, Greg Tuorto of Goldman Sachs joined CNBC's 'Closing Bell' to state that the small-cap market is starting to show signs of life.
Biodesix, Inc. (NASDAQ:BDSX) Q1 2025 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Biodesix's Q1 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Biodesix, Inc. (NASDAQ:BDSX) Q4 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Biodesix, Inc. Q4 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
12 Penny Stocks with Insider Buying in 2025
Insider trading can be a reliable signal for gauging the degree of confidence that management has in the future of their company.
Biodesix, Inc. (NASDAQ:BDSX) Q3 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to Biodesix, Inc. Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Biodesix, Inc. (NASDAQ:BDSX) Q2 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Biodesix Q2 2024 Earnings Conference Call. [Operator Instructions]. I would now like to hand the conference over to your speaker today.
Hedge Fund Resource Center